Misa Imai

852 total citations
23 papers, 536 citations indexed

About

Misa Imai is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Misa Imai has authored 23 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 16 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Misa Imai's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Acute Myeloid Leukemia Research (8 papers) and Kruppel-like factors research (7 papers). Misa Imai is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Acute Myeloid Leukemia Research (8 papers) and Kruppel-like factors research (7 papers). Misa Imai collaborates with scholars based in Japan, United States and Netherlands. Misa Imai's co-authors include Marito Araki, Norio Komatsu, Anton C. Martens, Tatsunori Goto, Nobuhiko Imahashi, Makoto Murata, Akihiro Tomita, Seitaro Terakura, Tom van Meerten and Kazuyuki Shimada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Misa Imai

20 papers receiving 528 citations

Peers

Countries citing papers authored by Misa Imai

Since Specialization

Citations

This map shows the geographic impact of Misa Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misa Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misa Imai more than expected).

Fields of papers citing papers by Misa Imai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misa Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misa Imai. The network helps show where Misa Imai may publish in the future.

Co-authorship network of co-authors of Misa Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Misa Imai. A scholar is included among the top collaborators of Misa Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misa Imai. Misa Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A marine sponge-derived lectin reveals hidden pathway for thrombopoietin receptor activation 2022 ·Nature Communications ·(unknown), (unknown), Nami Masubuchi, (unknown), (unknown), Pamela J. Focia, (unknown), Takashi Matsui, Yoshio Kodera, Tomohisa Ogawa, Takeshi Yokoyama, Makoto Hirayama, Kanji Hori, Douglas Freymann, Misa Imai, Norio Komatsu, Marito Araki, Yoshikazu Tanaka, Ryuichi Sakai	0
2	Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms 2022 ·Experimental Hematology ·Chang Liu, Misa Imai, Yoko Edahiro, (unknown), (unknown), (unknown), Akira Kurose, Soji Morishita, Miki Ando, Satoshi Tsuneda, Marito Araki, Norio Komatsu	0
3	Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasms 2022 ·Leukemia Research ·Federico De Marchi, (unknown), Soji Morishita, Misa Imai, (unknown), (unknown), (unknown), (unknown), (unknown), Yinjie Yang, Jun Ando, Miki Ando, Marito Araki, Norio Komatsu	0
4	MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations 2021 ·International Journal of Hematology ·(unknown), (unknown), (unknown), Huixin Li, Daisuke Watanabe, Hiroki Akiyama, Kouhei Yamamoto, (unknown), Yuho Najima, Noriko Doki, Emiko Sakaida, Yoko Edahiro, Misa Imai, Marito Araki, Norio Komatsu, Osamu Miura, Norihiko Kawamata	3
5	Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia 2021 ·Scientific Reports ·(unknown), Marito Araki, Soji Morishita, Misa Imai, (unknown), (unknown), Yinjie Yang, Masafumi Ito, Satoshi Osaga, Hiroyuki Mano, Yoko Edahiro, Tomonori Ochiai, (unknown), (unknown), Jun Ando, Norio Komatsu	7
6	CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome–negative myeloproliferative neoplasms 2020 ·Cancer Science ·Soji Morishita, Hajime Yasuda, (unknown), Hideya Kawaji, Masayoshi Itoh, Yoko Edahiro, Misa Imai, Yasushi Kogo, Satoshi Tsuneda, Akimichi Ohsaka, Yoshihide Hayashizaki, Masafumi Ito, Marito Araki, Norio Komatsu	9
7	Therapeutic Potential of an Antibody Targeting the Cleaved Form of Mutant Calreticulin in Myeloproliferative Neoplasms 2020 ·Blood ·(unknown), Marito Araki, Misa Imai, (unknown), (unknown), (unknown), (unknown), (unknown), Nami Masubuchi, Yo Mabuchi, Yinjie Yang, (unknown), Soji Morishita, Takehiro Suzuki, (unknown), Motoyuki Shimonaka, Chihiro Akazawa, Akimichi Ohsaka, Norio Komatsu	8
8	Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface 2019 ·Leukemia ·Nami Masubuchi, Marito Araki, Yinjie Yang, (unknown), Misa Imai, Yoko Edahiro, Yumi Hironaka, Yoshihisa Mizukami, (unknown), (unknown), (unknown), Masato Koike, Akimichi Ohsaka, Norio Komatsu	37
9	Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan 2019 ·European Journal Of Haematology ·Yoko Edahiro, Marito Araki, (unknown), Masafumi Ito, Soji Morishita, (unknown), (unknown), Misa Imai, Akimichi Ohsaka, Norio Komatsu	10
10	JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera 2019 ·British Journal of Haematology ·(unknown), Marito Araki, Soji Morishita, Misa Imai, Hajime Yasuda, (unknown), Masafumi Ito, Yoko Edahiro, Tomonori Ochiai, (unknown), (unknown), Akimichi Ohsaka, Norio Komatsu	7
11	Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation 2018 ·Leukemia ·Marito Araki, Yinjie Yang, Misa Imai, Yoshihisa Mizukami, (unknown), Yoshitaka Sunami, Nami Masubuchi, Yoko Edahiro, Yumi Hironaka, Satoshi Osaga, Akimichi Ohsaka, Norio Komatsu	43
12	Somatic mutations of calreticulin in myeloproliferative neoplasms 2017 ·International Journal of Hematology ·Misa Imai, Marito Araki, Norio Komatsu	26
13	Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells 2017 ·Journal of Biological Chemistry ·Yoshitaka Sunami, Marito Araki, Shin Kan, Akihiro Ito, Yumi Hironaka, Misa Imai, Soji Morishita, Akimichi Ohsaka, Norio Komatsu	20
14	Simple and Efficient Generation of Virus-specific T Cells for Adoptive Therapy Using Anti-4-1BB Antibody 2015 ·Journal of Immunotherapy ·Nobuhiko Imahashi, Tetsuya Nishida, Tatsunori Goto, Seitaro Terakura, Keisuke Watanabe, Ryo Hanajiri, Reona Sakemura, Misa Imai, Hitoshi Kiyoi, Tomoki Naoe, Makoto Murata	4
15	Environmental carcinogenesis – 100th anniversary of creating cancer 2015 ·Cancer Science ·Misa Imai, Okio Hino	6
16	Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells 2014 ·The Journal of Immunology ·Keisuke Watanabe, Seitaro Terakura, Anton C. Martens, Tom van Meerten, Susumu Uchiyama, Misa Imai, Reona Sakemura, Tatsunori Goto, Ryo Hanajiri, Nobuhiko Imahashi, Kazuyuki Shimada, Akihiro Tomita, Hitoshi Kiyoi, Tetsuya Nishida, Tomoki Naoe, Makoto Murata	223
17	Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity 2012 ·Proceedings of the National Academy of Sciences ·Johanna I. Partanen, Topi A. Tervonen, (unknown), (unknown), Misa Imai, Pekka Katajisto, Gerrit J.P. Dijkgraaf, Panu E. Kovanen, Tomi P. Mäkelä, Zena Werb, Juha Klefström	66
18	Effects of dichloroaeetate in three patients with MELAS 1998 ·Neurology ·Shinji Saitoh, Mariko Y. Momoi, Takanori Yamagata, Yusaku Mori, Misa Imai	38
19	[Complete remission in a patient with acute megakaryoblastic leukemia]. 1984 ·PubMed ·Misa Imai, (unknown), Y Enomoto, Y Watanabe	1
20	[A case of primary myelofibrosis terminating in acute megakaryoblastic leukemia: identification by the demonstration of platelet peroxidase]. 1984 ·PubMed ·(unknown), Masaharu Takigawa, (unknown), Kazuo Oshimi, H Mizoguchi, Michiko Okada, Y Enomoto, Y Watanabe, Misa Imai	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact